- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 31/655 - Composés azoïques(-N=N-), diazoïques (=N2), azoxy (N-O-N ou N(=O)-N), azido (-N3) ou diazoamino (-N=N-N)
Détention brevets de la classe A61K 31/655
Brevets de cette classe: 586
Historique des publications depuis 10 ans
|
40
|
41
|
46
|
40
|
52
|
67
|
41
|
33
|
29
|
12
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Johns Hopkins University | 5825 |
13 |
| Ligand Pharmaceuticals Incorporated | 169 |
13 |
| Know bio, LLC | 81 |
12 |
| Kyoto University | 2892 |
8 |
| The General Hospital Corporation | 4827 |
7 |
| The Scripps Research Institute | 1341 |
7 |
| Bristol-myers Squibb Company | 4811 |
6 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2973 |
6 |
| The Regents of the University of California | 20574 |
5 |
| President and Fellows of Harvard College | 6045 |
5 |
| Boston Medical Center Corporation | 115 |
5 |
| Jiangsu Hengrui Medicine Co., Ltd. | 695 |
5 |
| Regeneron Pharmaceuticals, Inc. | 4618 |
5 |
| Salix Pharmaceuticals, Inc. | 83 |
5 |
| Merck Sharp & Dohme LLC | 3729 |
5 |
| Novartis AG | 10327 |
4 |
| Novartis Pharma AG | 180 |
4 |
| Warsaw Orthopedic, Inc. | 2812 |
4 |
| Mayo Foundation for Medical Education and Research | 3355 |
4 |
| Duke University | 3166 |
4 |
| Autres propriétaires | 459 |